I agree, but while the monthly prescriptions or sales information is price sensitive once released, I don’t think these are compulsory. We have just become used to them! So they can wait and release whatever they want as long as they satisfy the normal reporting guidelines.
That’s my understanding, anyway. Correct me if I’m wrong.
Bod Pharmaceuticals & collaborations, page-11
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable